Match!
Suzanne V. Arnold
University of Missouri–Kansas City
295Publications
30H-index
2,671Citations
Publications 295
Newest
#1Suzanne J. Baron (Lahey Hospital & Medical Center)
#2Kaijun WangH-Index: 21
Last.William T. Abraham (OSU: Ohio State University)H-Index: 94
view all 10 authors...
Background: The COAPT trial demonstrated that edge-to-edge transcatheter mitral valve repair (TMVr) using the MitraClip resulted in reduced mortality and heart-failure hospitalizations and improved...
#1Suzanne V. ArnoldH-Index: 30
#2J.A. de LemosH-Index: 80
Last.Christopher P. CannonH-Index: 131
view all 10 authors...
Patients with atherosclerotic cardiovascular disease (ASCVD) and concomitant diabetes are at particularly high risk for new and recurrent ischemic events and heart failure and therefore derive grea...
#1Mayank Sardana (UCSF: University of California, San Francisco)H-Index: 7
#2Yuanyuan TangH-Index: 7
Last.David D. McManus (UMMS: University of Massachusetts Medical School)H-Index: 36
view all 10 authors...
Background Studies show suboptimal provision of smoking cessation assistance (counseling or pharmacotherapy) for current smokers attempting to quit. We aimed to identify smoking cessation assistanc...
#1Suzanne V. ArnoldH-Index: 30
#2Mikhail KosiborodH-Index: 44
Last.Leo SemanH-Index: 10
view all 8 authors...
Background: Heart failure (HF) is one of the most common and morbid complications of T2D. Prompt recognition of early signs of HF may avert HF hospitalization and may also impact T2D meds (e.g., TZDs or possibly SGLT2i). We determined the rate and factors associated with HF diagnosis in T2D patients with evidence of volume overload requiring loop diuretics. Methods: DCR is a U.S. registry of outpatient T2D patients from 3074 cardiology, endocrinology, and primary care providers. Among T2D patien...
Background: Thiazolidinediones (rosiglitazone, pioglitazone) are oral insulin-sensitizing medications used in type 2 diabetes mellitus that reduce glucose with minimal risk of hypoglycemia and pote...
Background: Survival and health status (eg, symptoms and quality of life) are key outcomes in clinical trials of heart failure treatment. However, health status can only be recorded on survivors, p...
#1Dzi Cherney (UHN: University Health Network)
#2Dc Wheeler (UCL: University College London)
Last.M Costa Rodrigues (AstraZeneca)
view all 9 authors...
12345678910